We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MP icon
2901
MP Materials
MP
$9.84B
$64.3K ﹤0.01%
5,049
-47,040
-90% -$739K
SLQT icon
2902
SelectQuote
SLQT
$122M
$64.3K ﹤0.01%
23,285
+17,984
+339% +$43.3K
SGC icon
2903
Superior Group of Companies
SGC
$204M
$64.3K ﹤0.01%
+3,398
New +$62.7K
FLGT icon
2904
Fulgent Genetics
FLGT
$523M
$64.3K ﹤0.01%
3,275
+1,609
+97% +$33.6K
SNCY
2905
DELISTED
Sun Country Airlines
SNCY
$64.1K ﹤0.01%
5,107
+3,007
+143% +$37.1K
GLRE icon
2906
Greenlight Captial
GLRE
$503M
$64.1K ﹤0.01%
4,896
+4,857
+12,454% +$61.9K
CRBU icon
2907
Caribou Biosciences
CRBU
$168M
$64.1K ﹤0.01%
39,101
+34,674
+783% +$111K
LICY
2908
DELISTED
Li-Cycle Holdings Corp.
LICY
$64.1K ﹤0.01%
9,820
+8,164
+493% +$45.1K
ABOS icon
2909
Acumen Pharmaceuticals
ABOS
$178M
$64.1K ﹤0.01%
26,488
+25,078
+1,779% +$79.8K
NRC icon
2910
NRC Health Common Stock
NRC
$473M
$63.8K ﹤0.01%
2,780
+2,630
+1,753% +$81.1K
BARK icon
2911
BARK
BARK
$96.8M
$63.8K ﹤0.01%
1,762
+1,387
+370% +$35.5K
TU icon
2912
Telus
TU
$15.2B
$63.7K ﹤0.01%
4,210
-30,297
-88% -$488K
EZU icon
2913
iShare MSCI Eurozone ETF
EZU
$9.91B
$63.7K ﹤0.01%
1,305
+39
+3% +$1.97K
ITI
2914
DELISTED
Iteris, Inc.
ITI
$63.6K ﹤0.01%
14,678
+14,565
+12,889% +$65.9K
LMNR icon
2915
Limoneira
LMNR
$254M
$63.5K ﹤0.01%
3,053
+2,807
+1,141% +$56.5K
NATH icon
2916
Nathan's Famous
NATH
$399M
$63.5K ﹤0.01%
937
+791
+542% +$53.5K
BSRR icon
2917
Sierra Bancorp
BSRR
$525M
$63.5K ﹤0.01%
+2,837
New +$58K
CCB icon
2918
Coastal Financial
CCB
$793M
$63.4K ﹤0.01%
1,373
+1,327
+2,885% +$55.8K
ARCO icon
2919
Arcos Dorados Holdings
ARCO
$1.67B
$63.2K ﹤0.01%
7,025
-3,658
-34% -$37.6K
SNY icon
2920
Sanofi
SNY
$104B
$63.2K ﹤0.01%
1,303
+589
+82% +$28.4K
FTS icon
2921
Fortis
FTS
$28.6B
$63.1K ﹤0.01%
1,624
-268
-14% -$10.6K
HBNC icon
2922
Horizon Bancorp
HBNC
$1.05B
$63K ﹤0.01%
5,096
+4,705
+1,203% +$56.6K
FVCB icon
2923
FVCBankcorp
FVCB
$335M
$62.9K ﹤0.01%
5,763
+5,301
+1,147% +$58.7K
PRAX icon
2924
Praxis Precision Medicines
PRAX
$10.3B
$62.8K ﹤0.01%
1,519
-329
-18% -$15.5K
TXG icon
2925
10x Genomics
TXG
$7.62B
$62.7K ﹤0.01%
3,222
-1,564
-33% -$41K

Similar funds

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.